0001104659-25-059529.txt : 20250613 0001104659-25-059529.hdr.sgml : 20250613 20250613200637 ACCESSION NUMBER: 0001104659-25-059529 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250529 FILED AS OF DATE: 20250613 DATE AS OF CHANGE: 20250613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myers Michael CENTRAL INDEX KEY: 0001959547 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37846 FILM NUMBER: 251048195 MAIL ADDRESS: STREET 1: AZRIELI CENTER STREET 2: ROUND TOWER, 30TH FLOOR CITY: TEL AVIV STATE: L3 ZIP: 6701101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quoin Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001671502 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 BUSINESS ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 BUSINESS PHONE: 97299741444 MAIL ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biotechnology Ltd. DATE OF NAME CHANGE: 20160721 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biomed Ltd. DATE OF NAME CHANGE: 20160406 4/A 1 tm2518028-4_4aseq1.xml OWNERSHIP DOCUMENT X0508 4/A 2025-05-29 2025-06-02 0 0001671502 Quoin Pharmaceuticals, Ltd. QNRX 0001959547 Myers Michael C/O QUOIN PHARMACEUTICALS LTD., 42127 PLEASANT FOREST COURT ASHBURN VA 20148 1 1 0 0 Chief Executive Officer 0 Share Option (Right to Buy) 9.07 2025-05-29 4 A 0 42857 0 A 2035-05-29 ADS 42857 42857 D The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer. On June 2, 2025, the reporting person filed a Form 4 which inadvertently understated the number of ADSs underlying the option granted to the reporting person on May 29, 2025. The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029. /s/ Michael Myers 2025-06-13